Emcure Pharmaceuticals Hits $1 Billion Revenue Milestone Driven by Weight-Loss Strategy
Emcure Pharmaceuticals officially surpassed $1 billion in annual revenue for the fiscal year ending March 31, 2026, a milestone the company attributes to the strategic expansion of its weight-loss portfolio. The Pune-based pharmaceutical giant successfully captured a significant market share with its flagship weight-management brand, Poviztra, positioning the firm as a major player in the…